BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17008708)

  • 1. Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study.
    Glynne-Jones R; Sebag-Montefiore D
    J Clin Oncol; 2006 Oct; 24(28):4664-5; author reply 4665-6. PubMed ID: 17008708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advantages of neoadjuvant therapy in rectal neoplasm].
    Nano M; Ferronato M; Solej M; D'Amico S
    G Chir; 2008 May; 29(5):197-202. PubMed ID: 18507953
    [No Abstract]   [Full Text] [Related]  

  • 3. Will we ever succeed in resolving the adjuvant treatment dilemma in rectal cancer?
    Petrelli NJ
    J Surg Oncol; 2003 Feb; 82(2):79-83. PubMed ID: 12561061
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
    Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival.
    Sprenger T; Rödel F; Beissbarth T; Conradi LC; Rothe H; Homayounfar K; Wolff HA; Ghadimi BM; Yildirim M; Becker H; Rödel C; Liersch T
    Clin Cancer Res; 2011 Mar; 17(6):1623-31. PubMed ID: 21118954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant therapy in pancreatic cancer].
    Ji JF; Li ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):644-7. PubMed ID: 16274051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant and neoadjuvant treatment of rectal cancer.
    Freedman GM; Coia LR
    Semin Oncol; 1995 Dec; 22(6):611-24. PubMed ID: 8539636
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in rectal cancer chemotherapy.
    Joseph M; Benson AB
    Cancer J; 2007; 13(3):198-203. PubMed ID: 17620770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
    Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation plus chemotherapy as adjuvant therapy for rectal cancer.
    Minsky BD
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):267-82. PubMed ID: 11969238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally advanced rectal cancer: what is the evidence for induction chemoradiation?
    Glynne-Jones R; Harrison M
    Oncologist; 2007 Nov; 12(11):1309-18. PubMed ID: 18055850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy.
    Papagrigoriadis S
    Br J Cancer; 2006 Oct; 95(7):950; author reply 951-2. PubMed ID: 17016488
    [No Abstract]   [Full Text] [Related]  

  • 14. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
    Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic markers of local relapse in rectal cancer: are we any further forward?
    Johnston PG
    J Clin Oncol; 2006 Sep; 24(25):4049-50. PubMed ID: 16943520
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neoadjuvant treatment of rectal cancer: towards an individualised therapy].
    Willeke F; Horisberger K; Post S
    Z Gastroenterol; 2006 Oct; 44(10):1053-63. PubMed ID: 17063435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to M. Mohiuddin et al.
    Dewdney A; Hawkes EA; Cunningham D
    J Clin Oncol; 2011 Jul; 29(19):2737-8. PubMed ID: 21850737
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients.
    Fietkau R; Klautke G
    J Clin Oncol; 2008 Jan; 26(3):507-8; author reply 508-9. PubMed ID: 18202428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.